The company’s decentralized systems and rapid growth created regulatory gaps that threatened vendor relationships and contract readiness. ICON also faced complex regulatory challenges when handling biomedical data, pharmaceutical research, and patient information in Russia, China, Ukraine, and India—each with its own evolving data security policies. Additionally, cross-border data transfers and vendor security raised concerns. PRA’s legal and compliance teams were under pressure to negotiate cybersecurity terms that would satisfy varying international laws, while ensuring ongoing vendor performance and risk mitigation.